The U.S. Food and Drug Administration is raising alarms about Librela, warning veterinarians of potential adverse effects, including death, in some dogs receiving the treatment.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Young people with a rare condition called Juvenile Idiopathic Arthritis (JIA) are taking part in clinical research to better ...

Identify triggers, recognize symptoms, and manage RA flare-ups effectively with lifestyle, medication, and support for better ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

Many dog owners have already heard about the FDA warning and seen the articles on the terrible side effects experienced by ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

The Kokomo woman was prediabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually prescribed ...

Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

A study shows GLP-1 weight-loss drugs reduce Alzheimer’s risk but increase arthritis, kidney, and pancreas issues.